Treatment methods for squamous cell carcinoma using farnesyltransferase inhibitors and PI3K inhibitors

JP2026518581APending Publication Date: 2026-06-09KURA ONCOLOGY INC
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
KURA ONCOLOGY INC
Filing Date
2024-05-07
Publication Date
2026-06-09

Smart Images

  • Figure 2026518581000009
    Figure 2026518581000009
  • Figure 2026518581000010
    Figure 2026518581000010
  • Figure 2026518581000001
    Figure 2026518581000001
Patent Text Reader

Abstract

This specification provides a method for using compound (I) or a pharmaceutically acceptable form thereof in optional combination with a PI3K inhibitor such as alpelisib to treat squamous cell carcinoma.
Need to check novelty before this filing date? Find Prior Art